Company: HMDCF
Filing Date: 2025-03-19
Form Type: 20-F
Source: 0001410578-25-000377
Chunk: 668

Company: HUTCHMED (China) Ltd
Filing Date: 2025-03-19
Form: 20-F
Item: Item 16K
Chunk 668
---
,474,713ordinary shares. The Company will issue new shares to satisfy share option exercises. Additionally, the number of shares authorized but unissued was628,398,905ordinary shares.

Share options granted are generally subject to afour-yearvesting schedule, depending on the nature and the purpose of the grant. Share options subject to thefour-yearvesting schedule, in general, vest25% upon the first anniversary of the vesting commencement date as defined in the grant letter, and25% every subsequent year. However, certain share option grants may have a different vesting schedule as approved by the Board of Directors of the Company. No outstanding share options will be exercisable or subject to vesting after the expiry of a maximum often yearsfrom the date of grant.

F-31

Table of Contents

A summary of the Company’s share option activity and related information is as follows:
Weighted average
Weighted average remaining Aggregate
Number of exercise price in contractual life intrinsic value
share options US$ per share (years) (in US$ ’ 000)
Outstanding at January 1, 2023 39,521,395 4.34 6.55 11,525
Granted 1,221,900 2.50
Exercised ( 6,480,930) 2.30
Cancelled ( 2,832,340) 4.61
Expired ( 1,893,370) 5.55
Outstanding at December 31, 2023 29,536,655 4.57 6.67 9,924
Granted (note) 2,965,328 3.69
Exercised ( 344,825) 2.29
Cancelled ( 892,600) 4.38
Expired ( 1,624,285) 5.23
Outstanding at December 31, 2024 29,640,273 4.47 5.99 3,804
Vested and exercisable at December 31, 2023 18,198,170 5.10 5.91 1,753
Vested and exercisable at December 31, 2024 21,186,120 4.92 5.13 1,387
Note: Includes aggregate2,765,328share options granted to an executive director. 1,359,561share options were granted in March 2024 and1